Lomidze, K.; Kikodze, N.; Gordeladze, M.; Charkviani, N.; Chikovani, T.
Complete Blood Count-Derived Biomarkers’ Association with Risk of PD-1 or PD-1/CTLA-4 Inhibitor-Induced Hypothyroidism in Patients with Solid Tumors. Immuno 2025, 5, 21.
https://doi.org/10.3390/immuno5020021
AMA Style
Lomidze K, Kikodze N, Gordeladze M, Charkviani N, Chikovani T.
Complete Blood Count-Derived Biomarkers’ Association with Risk of PD-1 or PD-1/CTLA-4 Inhibitor-Induced Hypothyroidism in Patients with Solid Tumors. Immuno. 2025; 5(2):21.
https://doi.org/10.3390/immuno5020021
Chicago/Turabian Style
Lomidze, Ketevan, Nino Kikodze, Marine Gordeladze, Nino Charkviani, and Tinatin Chikovani.
2025. "Complete Blood Count-Derived Biomarkers’ Association with Risk of PD-1 or PD-1/CTLA-4 Inhibitor-Induced Hypothyroidism in Patients with Solid Tumors" Immuno 5, no. 2: 21.
https://doi.org/10.3390/immuno5020021
APA Style
Lomidze, K., Kikodze, N., Gordeladze, M., Charkviani, N., & Chikovani, T.
(2025). Complete Blood Count-Derived Biomarkers’ Association with Risk of PD-1 or PD-1/CTLA-4 Inhibitor-Induced Hypothyroidism in Patients with Solid Tumors. Immuno, 5(2), 21.
https://doi.org/10.3390/immuno5020021